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Abstract
Background: The Cancer Registry of Crete is a regional population database that collects cancer morbidity/mortality
data along with several risk factors. The current study assessed the geographical variation of lung cancer among ever
and never smokers in Crete during the last 20 years.
Method: Lung cancer patient records (1992–2013) including information on medical history and smoking habits were
obtained from the Cancer Registry of Crete. Age-Adjusted Incidence Rates (AAIR), prevalence of smoking among lung
cancer patients and the Population-Attributable Fraction (PAF%) of tobacco smoking were estimated. Kaplan-Meier
curves, grouped per smoking status were constructed, and spatio-temporal analyses were carried out to assess the
geographical variations of lung cancer and smoking (a = 0.05).
Results: New lung cancer cases in Crete accounted for 9% of all cancers (AAIRboth genders = 40.2/100,000/year,
AAIRmales = 73.1/100,000/year, AAIRfemales = 11.8/100,000/year). Ever smokers presented significantly higher incidence
compared to ex-smokers (p = 0.02) and never smokers (p < 0.001). The highest increase was observed in ever smokers
(AAIR1992 = 19.2/100,000/year, AAIR2013 = 25.4/100,000/year, p = 0.03), while never smokers presented the lowest
increase from 1992 to 2013 (AAIR1992 = 5.3/100,000/year, AAIR2013 = 6.8/100,000/year, p = 0.2). The PAF% of lung
cancer mortality is 86% for both genders (males: 89%, females: 78%). AAIRs ranged from 25 to 50/100,000/
year, while significant geographical differences were observed among the municipalities of Crete (p = 0.02).
Smokers living in the south-east urban regions presented higher risk of dying from lung cancer (RR = 2.2;
95%CI = 1.3–3.5).
Conclusions: The constant increase of lung cancer rates among both genders, especially in females, outlines
the need for targeted, geographically-oriented, life-style preventive measures. Design of population-based
screening programs, tobacco awareness campaigns and smoking cessation programs in lung cancer hot spots
could be guide by these findings.
Background
Tobacco smoking is the leading preventable cause of
morbidity and mortality worldwide [1]. Exposure to to-
bacco has a negative impact on health across life-course
[1, 2]. Tobacco smoking is responsible for more than 5
million deaths per year, while it is estimated that this
figure will increase to approximately 8 million deaths in
2030 [2]. Tobacco control has been addressed in many
comprehensive cancer control strategies, since tobacco
smoking accounts for 74% of trachea, bronchus, and
lung cancers [3]. Lung cancer epidemic is now receding
in several nations in which tobacco control has managed
to reduce smoking, whereas it is rapidly rising in other
regions [4].
Lung cancer incidence and mortality present geo-
graphic and temporal trends that are strongly deter-
mined by tobacco smoking pattern, which is considered
the major risk factor in lung carcinogenesis [5]. Despite
the success in identifying tobacco smoking as the major
risk factor for lung cancer, this highly preventable
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disease remains among the most common and most le-
thal cancers globally, even in developed countries [4, 5].
Further studies on the relation of lung cancer with to-
bacco smoking are needed at a regional/country level to
explore local particularities and understand the effects of
risk factors [6–9].
Epidemiology of lung cancer in Greece has been ex-
tensively reported in the literature, with several studies
suggesting that lung cancer has the highest disease-
specific smoking Population Attributable Fraction (PAF%),
ranging from 88.4 to 89% [10, 11]. However, community-
based epidemiological studies are scarce in Greece. In
addition, there are no national databases or studies that
could have already undertaken these efforts. Systematic
reports on cancer incidence and mortality are also consid-
ered a neglected issue. This gap is partially filled by the
Cancer Registry of Crete (http://www.crc.uoc.gr), which is
the only population-based regional cancer registry in
Greece, with a big-database of more than two decades’ re-
cords [12]. The aim of registry is to monitor the progress
of malignant neoplasms and report on cancer-attributed
morbidity and mortality, identify cancer hot spots and es-
timate the future burden of the disease in Crete.
According to previous studies of the Cancer Registry
of Crete, heterogeneous lung cancer trends are expected
over Crete, regardless the island’s genetically homoge-
neous population [12]. Crete has been traditionally char-
acterized by no racial or religious deviations, has mainly
rural or semirural municipalities, as well as high occupa-
tional rates in the agricultural and business (i.e. tourism)
sector. Furthermore, the nutritional habits of the Cretan
population have been noted in the literature as being
most beneficial for health [13]. The traditional Cretan
diet was rich in vegetables, fruits, and olive oil [12, 13],
but major changes have occurred during the last decades
marking an increase in fast-food and sweets [14]. Con-
trary to their diet, Cretans usually show high rates of
cigarettes and alcohol consumption among men, while
the latest differences in lifestyle (increase of smoking for
both genders, especially females; increase in occupa-
tional and environmental exposures along with the
higher burden of multi-morbidity) are considered pos-
sible pathways through which individual characteristics
might impact on lung cancer mortality [12, 15]. These
variations should be assessed at a sub-regional level and
further explored towards identifying potential clusters or
significant differences of disease distribution in space.
The current study aimed to probe into the burden of
lung cancer in Crete, according to the demographic
characteristics and smoking habits (ever/never smokers)
of lung cancer patients. Among its primary objectives
was to monitor the geographical patterns of lung cancer
incidence and mortality rates and assess smoking burden
per municipality. Secondary objectives were to estimate
the effect of smoking in Years of Potential Life Lost
(YPLL) and attempt an in-depth exploration of the risk
factors for lower survival rates.
Methods
Setting and data sources
The current population-based study was conducted in
Crete, as a part of the Cancer Registry of Crete’s activ-
ities. The registry covers approximately 590,000 perman-
ent residents, while administratively comprised of four
counties and nineteen municipalities. The registry has
recently enhanced its capacity and methodological ap-
proach of collecting and analyzing data. A new cancer
monitoring system was developed towards this direction.
Highly trained registrars are responsible for collecting
data by distance, from two main sources of information:
public hospitals for morbidity data, and death registries
for mortality data. Data are directly coded according to
the international classification system for Oncology
(ICD10-O-2) [16]. Quality controls on the stored data
are performed at three levels: a) automatically by the
cancer monitoring system to identify and alert for dupli-
cated or missing cases (in 100% of the data), b) by an
epidemiologist to formulate the final version of the data-
base with complete and qualitative records (follow-up in
100% of the data) and c) by an oncologist to randomly
re-check 50% of the records per registrar back to the
primary sources of information. An overall quantitative
and qualitative control is performed annually towards
measuring three major quality indicators that are widely
recognized to enhance cancer control [17]: complete-
ness = 98%, validity/accuracy = 97%, and timeliness =
99%. In addition, the capture-recapture method is used
to capture potentially missing new cancer cases that
haven’t attended a Cretan hospital. The main sources of
information for this process are the Greek capital city hos-
pitals and the Hellenic Statistical Authority. The identified
missing percentage was 0.3% for lung cancer patients.
For the purposes of the current study, records on lung
cancer from 1992 to 2013 were obtained from the cancer
monitoring system. Data included information on patient’s
demographic profile, personal and family medical history,
and lifestyle factors (smoking habits, alcohol consump-
tion). The main inclusion criteria were: 1) cases with pri-
mary lung cancer, 2) individuals that have been residing in
Crete for at least the past 10 years, 3) a histologically or
cytologically confirmed diagnosis of lung cancer.
Measurements
Age-Standardized Incidence Rates (ASIR) and the Age-
Standardized Mortality Rates (ASMR) were estimated
using the direct standardization method, based on the
European Standard population of 2011 [18]. All rates
were estimated both for the entire island and per
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municipality of Crete, and were expressed as ASIR/
100,000/year. In addition, prevalence (%) of smoking
among lung cancer patients and smoking Population
Attributed Fraction (PAF%) [19] of lung cancer mortality
were estimated. Furthermore, the average smoking-
attributable YPLL [20] for smokers and non-smokers was
estimated per gender and age group.
Statistical and spatial analysis
The analysis was performed in R (Design.9 module) and
ArcMap 10.3.1., while all tests were conducted at a 0.05
level of significance. All rates and ratios were aggregated
and mapped per municipality, while they were compared
using the Kruskal-Wallis test (k > 2). A modified version
of the local Moran’s Index [21–23] was computed to es-
timate the overall tendency of lung cancer data for
spatial clustering according to smoking pattern status
(ever smokers and never smokers). Moran’s Index is a
statistic that quantifies spatial auto-correlation (similar-
ity in space) of attribute values, and is used to estimate
whether health parameters, such as lung cancer mortal-
ity data, are randomly distributed in space or exhibit
tendency for (global) clustering. Moran’s index attains
values from −1 to +1, indicating negative and positive
spatial autocorrelation respectively. Furthermore, a zero
value indicates a random spatial pattern with no overall
clustering. The modified Index was proposed by Jackson















where yi are counts, y bar is the mean of the count data,
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wij ¼ 1 if i;j are adjacent neighbors
0 otherwise
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In addition, 10-year Net-Survivals (%) were estimated
for never and ever smokers per gender. Survival was
measured from time of diagnosis until the date of death;
multiple regression analysis was performed using Cox
proportional hazards models. This procedure led to a
survival prediction model by identifying the significant
covariates to be included in the model (age: 25–44, 45–
54, … < 85 years; gender: males, females; stage: I, II, III,
IV, not known; personal medical history: no, lung dis-
ease, other cancer, not available/reliable; family medical
history: no, lung cancer, lung disease, not available/reli-
able; smoking status: never smoker, ever smoker, not
known). The survival prediction model was projected for
5 years and was internally validated by measuring both
discrimination and calibration, using the concordance
index (C-index) and a calibration curve respectively [24].
Both measures indicated the robustness of the prediction
model (C-index = 0.86) [25].
Results
Burden of lung cancer in Crete
There were 5,509 primary lung cancer records in the
Cancer Registry of Crete’s database from 1992 to 2013.
Their characteristics are presented in Table 1. Most of
them were males (87.3%) aged >65 years old (age group
of 65–74; 35.2%) Additionally, most patients (45.5%)
were diagnosed with stage IV and 16.1% with stage IIIA
and IIIB. Approximately, 50.9% of the patients had pre-
vious medical diagnosis of other lung disease (mainly
COPD) and 3.8% had a diagnosis of a second primary
tumor. The family medical history of chronic lung
diseases or lung cancer was also found to vary signifi-
cantly among lung cancer patients (p = 0.04). Among
those who had family medical history, 49.1% had a
member of their family with COPD, or chronic bron-
chitis, or emphysema, while lung cancer was diag-
nosed in 18.5% of them.
Furthermore, tobacco smoking was found to be signifi-
cantly correlated with the lung cancer diagnosis (p = 0.01).
The majority (75.1%) of lung cancer patients were ever
smokers (current or ex smoker), while 16.8% were never
smokers. Similar patterns were observed in lung can-
cer cases consuming alcohol, with 35% to be current
or former consumers and 25% not to consume alco-
hol (p = 0.04).
The AAIR varied significantly from 1992 to 2013, for
both genders (AAIR1992 = 34.9/100,000, AAIR2013 = 45.9/
100,000, p = 0.02). In addition, lung cancer was more fre-
quent (p = 0.01) in males (AAIR = 73.1/100,000/year)
compared to females (AAIR = 11.8/100,000/year). Never-
theless, females presented higher proportional increasing
trends (AAIR1992 = 8.2/100,000, AAIR2013 = 18.9/100,000,
p < 0.001), especially after 2008 compared to males.
Major differences were observed according to smoking
status, as illustrated in Fig. 1a. Ever smokers presented
significantly higher incidence of lung cancer compared
to ex-smokers (p = 0.02) and never smokers (p < 0.001).
All rates presented increasing trends with a significant
peak in 2001–2002 (p = 0.03). The highest increase of
approximately 6 new cases/100,000 population was ob-
served in ever smokers (AAIR1992 = 19.2/100,000/year,
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AAIR2013 = 25.4/100,000/year, p = 0.03), while never
smokers did not present a significantly different increase
of lung cancer incidence from 1992 to 2013 (AAIR1992 =
5.3/100,000/year, AAIR2013 = 6.8/100,000/year, p = 0.2)
(Fig. 1b). Male ever smokers had greater AAIR (AAIR1992–
2013 = 36.8/100,000/year), while male never smokers
(AAIR1992–2013 = 10.7/100,000/year) presented slightly
higher rates compared to female ever smokers (AAIR1992–
2013 = 6.9/100,000/year). Notably, there was no significant
difference of lung cancer incidence in female ex-smokers
and never smokers during the period 1992–2013, contrary
to the statistically significant increase of the incidence of
lung cancer in ever smokers (AAIR1992 = 4.1/100,000/year,
AAIR2013 = 10.3/100,000/year, p = 0.03).
Geographical variation of lung cancer and smoking habits
The spatial variation of AAIRs is presented in Fig. 2.
Rates ranged from 25/100,000/year to 50/100,000/year,
while significant geographical differences were observed
among the municipalities of Crete (p = 0.02). Munici-
palities with codes 8; 9; 16; 17 and 21 presented the
highest lung cancer burden. In addition, the municipal-
ities of south-east Crete were found to have increased
incidence of lung cancer (AAIRs = 40.01-45/100,000/
year). Furthermore, two municipalities (codes: 0; 13)
presented the lowest lung cancer incidence, ranging
from 25 to 30 new cases/100,000/year. Overall, munici-
palities with medium or high incidence rates (40.01-50/
100,000/year) presented higher percentage of ever
smokers (≥55%, p < 0.001).
ASMRs along with the PAFs are mapped per muni-
cipality in Fig. 3. ASMRs vary significantly among
municipalities (ASMRs = 20-45/100,000/year, p = 0.01).
Eight municipalities (codes: 4; 5; 8; 9; 15; 17; 21 and 22)
were found to have increased mortality (ASMRs = 40.01-
45/100,000/year) compared to the lowest rates observed
in the south-west municipalities of the island, as well as in
municipalities encoded 1 and 14 (ASMRs = 20-30/
100,000/year). The PAFs (34-90%) seem to follow the lung
cancer mortality pattern, with municipalities of increased
burden presenting significantly higher PAFs (p < 0.001). In
municipalities encoded 8 and 9 PAFs reach 87.9% and
86.3%, respectively.
When exploring overall lung cancer clustering accord-
ing to smoking patterns, results from the Moran’s Index
yielded a high power of 98% with potential clusters includ-
ing 30% of the population and an overall positive value of
spatial autocorrelation (Morans’I = 0.7). The central and
south-east municipalities of the island presented a higher
risk for lung cancer (RR = 2.2. 95% CI = 1.3-3.5).
Impact of smoking to lung cancer YPLL
Furthermore, Table 2 demonstrates the average YPLL
and PAFs attributed to lung cancer, according to gen-
der and age in Crete. Males had higher PAF (89%),
compared to females (78%). Accordingly, male ever
smokers presented slightly higher YPLL (16) than
female (YPLL = 15). Nevertheless, females (YPLLnever
smokers = 9; YPLLever smokers = 15) compared to males
(YPLLnever smokers = 11; YPLLever smokers = 16),
Table 1 Characteristics of lung cancer patients in Crete (1992
to 2013)
Characteristics Lung cancer cases P value
















Not known 1008 18.3
Personal medical history 0.04
No 2572 50.9






Not available/reliable 564 11.2
Family medical history 0.04
No 760 15
LC 937 18.5
Lung disease (COPD, Chronic
Bronchitisemphysema)
2485 49.1
Not available/reliable 875 17.3
Smoking status* 0.01
Never smoker 925 16.8
Ever smoker 4132 75.1




Not known 2176 39.5
*Pooled data: N = 5,057 lung cancer cases with information on smoking status
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Fig. 1 Age-Adjusted Incidence Rates per smoking category (a) and gender (b) in Crete from 1992 to 2013
Fig. 2 Geographical distribution of Age-Adjusted Incidence Rates/100,000/year and smoking proportion in Crete
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presented a higher difference of YPLLs between never
and ever smokers. In addition, ever smokers pre-
sented significantly higher YPLL (p = 0.03), regardless
of age. The age groups of 25–39 years and 40–
54 years were found to have increased YPLL for both
smoking categories, while lung cancer patients aged
40–54 years and 55–64 years had the highest difference of
YPLL between never and ever smokers (40–54 years:
YPLLnever smokers = 15; YPLLever smokers = 23; 55–64 years:
YPLLnever smokers = 7; YPLLever smokers = 15). Furthermore,
PAFs ranged from 57 to 92 according to age group, with
elder individuals to present higher portions (91-92%
among >65 years).
Survival and lung cancer risk factors
Table 3 presents the results of the Cox multivariate
regression analysis in lung cancer patients, which
identified significant covariates for inclusion in the
prediction survival model. Males (β = 0.6; 95%CI = 1.2-
1.4) and patients at stage IV (β = 1.6; 95%CI = 4.2-4.4)
were more likely to die from lung cancer. Higher age
(β = 0.9; 95%CI = 1.9-2.3), personal and family medical
history (β = 0.9; 95%CI = 1.3-2.3 and β = 0.5; 95%CI =
1.1-1.5 respectively) and ever smokers (β = 1.8; 95%CI =
1.3-1.7) presented significantly higher risk.
Figure 4 illustrates the Net-Survival (%) of lung can-
cer patients in Crete, after the first 10 years from diag-
nosis. Overall, females had better survival rates
compared to males, both in ever (5 years Net-
survivalfemales = 12.8%; 5 years Net-survivalmales = 10.6%)
and never smokers (5 years Net-survivalfemales = 22.5%;
5 years Net-survivalmales = 16.3%). Similar differences
were expected within the next 7 years according to the
predicted Net-survival (ever smokers: 5 years Net-
survivalfemales = 11.7%; 5 years Net-survivalmales = 9.8%
and never smokers: 5 years Net-survivalfemales = 23.1%;
5 years Net-survivalmales = 16.5%). Nevertheless, pre-
dicted survival indicated slight decreases for both
genders compared to the observed one, especially in
female ever smokers even from the first year after diag-
nosis (Observed survival: 1 year Net-survivalfemales =
38.7%; 1 year Net-survivalmales = 33.2% and predicted sur-
vival: 1 year Net-survivalfemales = 37.6%; 1 year Net-
survivalmales = 32.4%).
Fig. 3 Geographical distribution of Age-Standardized Mortality Rates/100,000/year and PAFs (%) in Crete
Table 2 Average YPLL and PAFs (%) between genders and
among age groups*
Characteristics Average YPLL (years) PAF (%)
Never smokers Ever smokers
Gender
Males 11 16 89
Females 9 15 78
Age group (at year of diagnosis)
25–39 35 40 57
40–54 15 23 88
55–64 7 15 89
65–79 4 7 91
> 80 0 0 92
*Pooled data: N = 5,057 lung cancer cases with information on smoking status
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Discussion
Key findings
This population-based epidemiological study provided new
evidence on lung cancer and tobacco smoking in Crete.
The major findings of this study conveyed new evidence
on lung cancer burden and its geographical variation in
Crete, while they reflected the strong impact of smoking
on lung cancer survival. In particular, the major findings of
this study were: a) the heterogeneous geographical pattern
of lung cancer, with municipalities of central and south-
east Crete that presented significantly higher rates espe-
cially for ever smokers; b) the observed temporal increases
of lung cancer, more significantly among males, and the
rapidly increasing rates among female ever smokers after
2001; c) the great number of YPLL in males, as well as the
significant difference of YPLLs among female ever and
never smokers; d) the significant impact of tobacco smok-
ing on lung cancer incidence and patients’ survival.
Discussion in the context of the literature
Tobacco smoking is widely recognized as the main cause
of premature death from lung cancer worldwide [26–28].
The causal relationship of lung cancer and smoking was
established in the 1950’s [26]. Since then, a large number
of studies in the literature have revealed the impact of to-
bacco smoking on lung cancer [27–31]. In particular, the
highest risk for lung cancer mortality in ever smokers has
been found to be approximately 9 times higher than in
never smokers [32]; much higher than the identified risk
in the current study. Similarly to our study, Tammemagi
et al., have stressed that smoking is an important inde-
pendent predictor of short-term lung cancer survival [27].
Furthermore, age was found to be a significant risk factor
in the current study. Larger proportions of lung cancer in-
cidence were observed among patients of age 55 and over.
This finding is in accordance with the literature especially
among ever smokers of this age group [32, 33].
In addition, place of residence seems to be a core com-
ponent of lung cancer incidence and mortality trends, as
highlighted by the current and other studies [34, 35]. It
is obvious that a wide range of factors, such as demo-
graphic, occupational and environmental, are linked with
rurality. These factors may have hidden effects on lung
cancer epidemics; such effects are more severe in geo-
graphical regions where prevalence of smoking is higher
(e.g., urban or semi-urban municipalities) [35]. Geo-
graphical inequalities in lung cancer incidence distribu-
tion may be observed due to the different smoking
habits between rural and urban regions. Marked differ-
ences in tobacco smoking patterns have been found in
Greece, among different geographical regions (rural vs
urban) and within age groups and genders [36]. Further-
more, the vast majority of Cretans consider smoking a
part of their culture which is strongly linked with social
activities of men, especially while socializing in trad-
itional “kafeneia” or modern cafes during the day [37].
This habit increases both active and passive smoking in
public and private working spaces, as well as inside the
house, especially in urban, densely populated regions.
Moreover, even though most of the municipalities in
Table 3 Cox Proportional Hazards Multivariate Regression
Analysis in lung cancer patients in Crete
Covariates β coefficient Hazard ratio 95% CI P value
Males 0.6 1.3 1.2–1.4 0.01
Age 0.9 2.1 1.9–2.3 0.01
Stage II 0.7 1.4 1.1–1.7 0.03
Stage III 0.7 1.4 1.2–1.6 0.02
Stage IV 1.6 1.9 1.8–2.0 <0.001
Personal medical history 0.9 1.8 1.3–2.3 0.03
Family medical history 0.5 1.3 1.1–1.5 0.02
Ever smoker 1.8 1.5 1.3–1.7 0.01
Alcohol consumption 0.3 1.1 0.4–1.8 0.8
Fig. 4 Observed and predicted lung cancer Net-survival among never and ever smokers, in Crete
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Crete are characterized as rural or semi-urban, their res-
idents still have a diverse demographic profile; this leads
to inequalities even between rural regions of the same
county [15]. Smoking prevalence in these regions may
have affected the lung cancer incidence rates, since, as
mentioned in the literature, individuals over 70 present
significantly lower smoking rates, or die from other
causes due to the lag period between tobacco exposure
and disease onset [38]. Apart from smoking, other occu-
pational and environmental risk factors may have an
additional effect on the increased lung cancer burden in
certain rural municipalities that presented high lung
cancer incidence and mortality. Greenhouse intense
farming is among the most common agricultural prac-
tices in some rural and semi-urban municipalities
(codes: 8; 9; 22). Studies has already shown the increased
risk of lung cancer mortality and lower survival among
individuals exposed to pesticides at work, especially
among female greenhouse workers [39, 40]. Previous
studies have documented the association of pesticides/
greenhouse farming and the development of chronic dis-
ease [41]. The projected lower survival rates in the
current study raise concern towards this direction.
Nevertheless, further research and additional field stud-
ies on the joint effect of smoking and other risk factors
(e.g. environmental exposures, lifestyle habits etc.) are
required in order to clearly demonstrate the existence of
such association in Crete.
YPLL due to lung cancer are higher in male ever-
smokers in most studies, while they present constantly
increasing temporal trends (1952: 6.6; 2012: 11.3) [42].
Nevertheless, the proportion of increase during the last
decades is higher in Cretan and Greek female ever-
smokers, indicating an urgent need for comprehensive
smoking policies that focus on women [43]. Public
health policies for tobacco control should consider the
time lag in the tobacco epidemic among women com-
pared to men, the differences in lifestyle and the local
particularities and needs per geographical region [43].
Impact of this study
The increasing rates of tobacco smoking and lung cancer
in Crete along with the projected lower survival rates
have stressed the need for integrated and effective can-
cer control with emphasis on screening [42]. Establish-
ment and acceptance of lung cancer screening as a
public health policy is still a neglected issue in Crete.
This is either due to low health literacy of the general
population, or due to accessibility issues. Other concerns
include risks of radiation, over diagnosis bias, proportion
of false positives and cost benefit analysis. Additionally,
barriers in successful engagement to smoking cessation
programs may have negatively affected lung cancer
trends in Crete. The findings of this study will be
utilized by the Region of Crete and the Health Region of
Crete, to boost smoking cessation [42, 43] in the island
and arm mobile lung cancer screening units in high risk
municipalities.
Furthermore, the Cancer Registry of Crete aims to de-
velop a multidisciplinary team of health care profes-
sionals to intervene in population groups at risk, and
conduct filed research to identify additional lung cancer
risk factors. General Practitioners (GPs) will have a key
role in this team with the aim to monitor lung cancer
patients, provide integrated and continuous care or re-
habilitation services, and raise awareness in the catch-
ment area of their Primary Health Care (PHC) unit and
promote healthy living in smoke-free places [44].
Strengths and limitations
Although this is the first study in Crete incorporating
data for more than 20 years, and the only one in Greece
on lung cancer incidence and tobacco smoking, a num-
ber of limitations may exist. Among these, the lack of
data on other potential risk factors (e.g. behavioral, oc-
cupational, and environmental) may have led to an over-
estimation of the impact of tobacco smoking on lung
cancer incidence despite the fact that our data are in
agreement with those of the literature [27, 32]. All rates
were aggregated at the municipality level, therefore the
exploration of causal relations between the exact place
of residence and lung cancer incidence is limited.
Nevertheless, the geographical distribution of lung
cancer rates and PAFs per municipality revealed numer-
ous spatial inequalities that provide valuable insights to
healthcare professionals, researchers and authorities.
Furthermore, this study differs from most of the studies
on lung cancer and tobacco smoking, since its findings
were exported from primary individual data. Last, it
should be noted that, as the Cancer Registry of Crete’s
database has undergone several quality controls, it con-
stitutes a reliable data base, and hence offers a robust
basis for studying the association of smoking with lung
cancer in the island of Crete. The reliable database of
the registry has undergone several quality controls as
mentioned in the methods section. Therefore, it is a ro-
bust tool for assessing the association of smoking with
lung cancer.
Conclusions
The findings of the current study provided rigorous evi-
dence that supports the strong relation between lung
cancer and tobacco smoking in Crete. The constantly in-
creasing trends of lung cancer incidences among ever
smokers, the identification of high risk areas and the
projected survival trends provided new evidence on the
current knowledge of lung cancer epidemiology in Crete.
Evidence conveyed from this study could support the
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design of targeted population-based screening programs,
lead tobacco awareness campaigns and plan smoking
cessation programs in lung cancer hot spots. Future re-
search will enhance knowledge on lung cancer epidemics
by exploring other risk factors such as environmental,
socio-economic and behavioral ones.
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